These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 15994308)
1. Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7. Wang H; Liu Y; Chen Y; Robinson H; Ke H J Biol Chem; 2005 Sep; 280(35):30949-55. PubMed ID: 15994308 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Huai Q; Wang H; Zhang W; Colman RW; Robinson H; Ke H Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9624-9. PubMed ID: 15210993 [TBL] [Abstract][Full Text] [Related]
3. Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity. Huai Q; Liu Y; Francis SH; Corbin JD; Ke H J Biol Chem; 2004 Mar; 279(13):13095-101. PubMed ID: 14668322 [TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity. Huai Q; Wang H; Sun Y; Kim HY; Liu Y; Ke H Structure; 2003 Jul; 11(7):865-73. PubMed ID: 12842049 [TBL] [Abstract][Full Text] [Related]
5. Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4. Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D Cell Signal; 2001 Apr; 13(4):287-97. PubMed ID: 11306246 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity. Scapin G; Patel SB; Chung C; Varnerin JP; Edmondson SD; Mastracchio A; Parmee ER; Singh SB; Becker JW; Van der Ploeg LH; Tota MR Biochemistry; 2004 May; 43(20):6091-100. PubMed ID: 15147193 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of phosphodiesterase 4D and inhibitor complex(1). Lee ME; Markowitz J; Lee JO; Lee H FEBS Lett; 2002 Oct; 530(1-3):53-8. PubMed ID: 12387865 [TBL] [Abstract][Full Text] [Related]
8. Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity. Wang H; Yan Z; Yang S; Cai J; Robinson H; Ke H Biochemistry; 2008 Dec; 47(48):12760-8. PubMed ID: 18983167 [TBL] [Abstract][Full Text] [Related]
9. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system. Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621 [TBL] [Abstract][Full Text] [Related]
10. Implications of PDE4 structure on inhibitor selectivity across PDE families. Ke H Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132 [TBL] [Abstract][Full Text] [Related]
11. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis. Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454 [TBL] [Abstract][Full Text] [Related]
12. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram. Xu RX; Rocque WJ; Lambert MH; Vanderwall DE; Luther MA; Nolte RT J Mol Biol; 2004 Mar; 337(2):355-65. PubMed ID: 15003452 [TBL] [Abstract][Full Text] [Related]
13. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases. Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978 [TBL] [Abstract][Full Text] [Related]
15. The role of tryptophan 1072 in human PDE3B inhibitor binding. Chung C; Varnerin JP; Morin NR; MacNeil DJ; Singh SB; Patel S; Scapin G; Van der Ploeg LH; Tota MR Biochem Biophys Res Commun; 2003 Aug; 307(4):1045-50. PubMed ID: 12878217 [TBL] [Abstract][Full Text] [Related]
16. Structural asymmetry of phosphodiesterase-9, potential protonation of a glutamic acid, and role of the invariant glutamine. Hou J; Xu J; Liu M; Zhao R; Luo HB; Ke H PLoS One; 2011 Mar; 6(3):e18092. PubMed ID: 21483814 [TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors. Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765 [TBL] [Abstract][Full Text] [Related]
18. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Cherry JA; Thompson BE; Pho V Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656 [TBL] [Abstract][Full Text] [Related]
19. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process. Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709 [TBL] [Abstract][Full Text] [Related]
20. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors. Kelly JJ; Barnes PJ; Giembycz MA Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]